BLACKMORES PROSTATE HEALTH FORMULA

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

Serenoa repens, Quantity: 160 mg (Equivalent: Serenoa repens, Qty 1.6 g; Equivalent: Fatty acids, Qty 144 mg); d-alpha-tocopherol, Quantity: 50.3 mg (Equivalent: d-alpha-tocopherol, Qty 75 IU); selenomethionine, Quantity: 125 microgram (Equivalent: selenium, Qty 50 microgram); Urtica dioica, Quantity: 150 mg (Equivalent: Urtica dioica, Qty 1.13 g; Equivalent: sitosterol, Qty 1.2 mg); zinc sulfate monohydrate, Quantity: 20.8 mg (Equivalent: zinc, Qty 7.5 mg); Lycopersicon esculentum, Quantity: 41.7 mg

Disponibbli minn:

Blackmores Ltd

INN (Isem Internazzjonali):

d-alpha-Tocopherol,Lycopersicon esculentum,Selenomethionine,Serenoa repens,Urtica dioica,Zinc sulfate monohydrate

Għamla farmaċewtika:

Capsule, soft

Kompożizzjoni:

Excipient Ingredients: hydrogenated vegetable oil; colloidal anhydrous silica; glycerol; purified water; lecithin; Gelatin; maltodextrin; iron oxide red; yellow beeswax; iron oxide black; Soya Oil

Rotta amministrattiva:

Oral

Indikazzjonijiet terapewtiċi:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Helps maintain/support testosterone formation/synthesis ; Help maintain/support healthy prostate function ; Maintain/support prostate health ; Maintain/support testosterone level ; Traditionally used in Western herbal medicine to Enhance/promote/increase urine output

Sommarju tal-prodott:

Visual Identification: ;

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2014-08-27